Oligonucleotide Therapeutics: Heading for Tons of Quantity in Annual Supply Need

被引：0

|

作者：

机构：

来源：

Genetic Engineering and Biotechnology News | 2020年 / 40卷 / 09期

关键词：

D O I：

10.1089/gen.40.09.06

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：24 / 25

页数：1

相关论文

共 7 条

[1] 9th Annual Meeting of the Oligonucleotide Therapeutics Society
Monia, Brett P.
NUCLEIC ACID THERAPEUTICS, 2013, 23 (06) : 450 - 458
[2] 5th CHI Annual Oligonucleotide & Precision Therapeutics (OPT) Congress
Croasdell, G.
DRUGS OF THE FUTURE, 2021, 46 (01) : 89 - 93
[3] CHI's 6th Annual Oligonucleotide & Precision Therapeutics (OPT) Congress Virtual - March 30-31, 2021
Komlos, D.
DRUGS OF THE FUTURE, 2021, 46 (06) : 487 - 492
[4] Antisense therapeutics - International Business Communications: Third annual symposium on oligonucleotide- and gene therapy-based antisense therapeutics - Coronado, CA, USA, 15-16 February 1996
Holt, J
MOLECULAR MEDICINE TODAY, 1996, 2 (05): : 184 - 185
[5] 10th Annual Meeting of the Oligonucleotide Therapeutics Society San Diego, California October 12-15, 2014 Session Summaries|
Gagnon, Keith T.
Watts, Jonathan K.
NUCLEIC ACID THERAPEUTICS, 2014, 24 (06) : 428 - 434
[6] 17th Annual Meeting of the Oligonucleotide Therapeutics Society: A Tribute to Bob Letsinger, Progress in N=1 Treatments, and Successful First In-Humans CRISPR Trials
Buijsen, Ronald A. M.
Lacroix, Aurelie
Ochaba, Joseph
O'Reilly, Daniel
Abdullahu, Leonora
McConnell, Erin M.
NUCLEIC ACID THERAPEUTICS, 2022, 32 (01)
[7] PRESERVING NUCLEAR-ENERGY SHARE IN THE ENERGY MIX CONTRIBUTING TO THE GERMAN POWER-SUPPLY - THE NEED FOR A SOLID POLITICAL BASE FOR A SECURE, ENVIRONMENTALLY SOUND, AND AFFORDABLE ELECTRICAL SUPPLY IN GERMANY - FROM THE OPENING ADDRESS DELIVERED AT THE 1993 ANNUAL NUCLEAR TECHNOLOGY CONFERENCE IN COLOGNE
BERKE, C
ATOMWIRTSCHAFT-ATOMTECHNIK, 1993, 38 (07): : 491 - 493